- About the Center
- Research Programs
- Addiction Genetics and Pharmacogenetics Division
- Addiction Treatment and Medication Development Division
- Brain-Behavioral Vulnerabilities Laboratory
- HIV/AIDS Prevention Research Division
- Clinical Trials Network
- Novel Interventions in Criminal Justice Populations Division
- Continuing Care and Assessment Division
- Integrated Care for Primary Care
- Clinical Trial Participation
- Treatment Options
- Affiliated Divisions
- Center Faculty
- Post Doctoral Fellowships
- Public Education and Policy Work
- Contact Us
- Support Our Work
Pharmacogenetic Response to Naltrexone for Alcohol Dependence
The Treatment Research Center directs a wide range of outpatient research programs for alcohol and drug dependent patients. Patients benefit from substance abuse research; specialists provide evaluation and treatment programs for substance abuse patients. Treatment encompasses psychotherapy, medication and rehabilitation.
Do you or someone you know suffer from alcohol dependence?
The Treatment Research Center is currently conducting a clinical research study in which participants will receive Naltrexone, an FDA-approved medication for alcoholism, or placebo, an inactive medication. If you or someone you know are interested, call 215-222-3200 ext. 156 for a confidential screening, or email Kim Colegrove for additional information.
Click on a link below for additional information:
Back to Top